FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-5.41%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$284M
AUM Growth
+$284M
(-25%)
Cap. Flow
-$71.1M
Cap. Flow
% of AUM
-25.08%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
3
Top Buys
No buys this quarter
Top Sells
| 1 |
Agios Pharmaceuticals
AGIO
|
$56.4M |
| 2 |
Cartesian Therapeutics
RNAC
|
$11.8M |
| 3 |
Carisma Therapeutics
CARM
|
$2.91M |
Sector Composition
| 1 | Healthcare | 97.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Seres Therapeutics
MCRB
$166M
| $143M | 50.54% |
12,682,876
| – | – |
|
|
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $77.3M | 27.27% |
4,806,656
| – | – |
|
3
Editas Medicine
EDIT
$231M
| $56.7M | 19.98% |
3,376,184
| – | – |
|
|
TTOO
4
DELISTED
T2 Biosystems, Inc
TTOO
| $6.26M | 2.21% |
1,950,583
| – | – |
|
|
5
Agios Pharmaceuticals
AGIO
$2.19B
| – | – |
-965,369
| Closed | -$56.4M |
|
|
6
Carisma Therapeutics
CARM
$8.98M
| – | – |
-1,324,018
| Closed | -$2.91M |
|
|
7
Cartesian Therapeutics
RNAC
$261M
| – | – |
-826,862
| Closed | -$11.8M |
|